Status:
COMPLETED
An Open-Label Clinical Study to Evaluate the Efficacy of a Face Cream and Eye Cream
Lead Sponsor:
Revision Skincare
Conditions:
Wrinkle
Photoaging
Eligibility:
FEMALE
35-65 years
Phase:
NA
Brief Summary
This single-center clinical trial is being conducted to assess the efficacy and tolerability of an anti-aging eye cream and face moisturizer when used over the course of 12 weeks twice-daily by women,...
Detailed Description
This was an institutional review board (IRB)-approved study. Female subjects, 35-65 years of age, Fitzpatrick skin type I-VI, with mild to moderate droopy eyelids, moderate crow's feet wrinkles, and m...
Eligibility Criteria
Inclusion
- Women between the ages of 35 and 65 years
- Women with Fitzpatrick skin type I-VI
- Subjects must have mild to droopy eyelids, moderate crow's feet wrinkles, and moderate photodamage
- Subjects must have no known medical conditions that, in the investigator's opinion, may interfere with study participation.
- Subjects must be willing to provide verbal understanding and written informed consent.
Exclusion
- Subjects which had a health condition and/or pre-existent dormant dermatological disease on the face
- Subjects that had any invasive or non-invasive skin treatments, or invasive medical procedures three months prior to the study
- Subjects that are unwilling to comply with the protocol
- Female subjects who are pregnant, breast feeding, or planning a pregnancy.
- Subjects who have any dermatological disorder, which in the investigator's opinion, may interfere with the accurate evaluation of the subject's skin, including rosacea, acne, and excessively oily or dry skin.
- Subjects who have demonstrated a previous hypersensitivity reaction to any of the ingredients of the study products.
- Subjects use of any medications that are known to potentially cause changes in the facial skin as determined by the Investigator.
- Subjects who spend excessive time out in the sun.
Key Trial Info
Start Date :
September 11 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 3 2021
Estimated Enrollment :
45 Patients enrolled
Trial Details
Trial ID
NCT04911374
Start Date
September 11 2020
End Date
February 3 2021
Last Update
October 6 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Stephens and Associates
Richardson, Texas, United States, 75081